Page last updated: 2024-10-30

lidoflazine and Leukemia P388

lidoflazine has been researched along with Leukemia P388 in 1 studies

Lidoflazine: Coronary vasodilator with some antiarrhythmic action.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research Excerpts

ExcerptRelevanceReference
"Uridine transport was also inhibited by nifedipine, verapamil, diltiazem, prenylamine and trifluoperazine, but only at similarly high concentrations in both human erythrocytes and the cell lines."1.27Effects of Ca2+-channel antagonists on nucleoside and nucleobase transport in human erythrocytes and cultured mammalian cells. ( Plagemann, PG; Woffendin, C, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plagemann, PG1
Woffendin, C1

Other Studies

1 other study available for lidoflazine and Leukemia P388

ArticleYear
Effects of Ca2+-channel antagonists on nucleoside and nucleobase transport in human erythrocytes and cultured mammalian cells.
    Biochimica et biophysica acta, 1987, May-18, Volume: 928, Issue:3

    Topics: Animals; Biological Transport; Calcium Channel Blockers; Cell Line; Erythrocytes; HeLa Cells; Humans

1987